Yoshito Zamami
Papers
1
Total Citations
17
H-Index
1
About
Yoshito Zamami is a leading researcher in pharmacoepidemiology and drug safety, with a particular focus on adverse drug reactions and real-world evidence. His work critically examines the safety profiles of widely used medications, notably through the analysis of spontaneous adverse event databases. In a landmark 2021 study, Zamami evaluated the potential complications of interstitial lung disease associated with antiandrogen therapies, a critical concern given the global surge in prostate cancer cases—from 679,023 in 2002 to over 1.27 million by 2018. This research, which has garnered 17 citations, provides essential insights for clinicians managing patients undergoing pharmacological treatment alongside total prostatectomy and radiation therapy. As Chief of the Department of Pharmacy, Zamami’s contributions have advanced the understanding of drug-induced toxicities, directly informing safer prescribing practices. His work exemplifies the vital role of pharmacovigilance in oncology, making him a key figure for students and researchers interested in the intersection of clinical pharmacy, big data analytics, and patient safety.
Research Focus
Key Achievements
Top Papers
- 1